2020年5月29日 / Last updated : 2022年3月31日 ad_n Fujita group

Masanori Oikawa

Research Fellow
Research Fellow
Field：Bioethics
Masanori Oikawa
Uehiro Research Division for iPS Cell of Ethics Center for iPS Cell Research and Application(CiRA)

I have been researching into ethical issues around medical research using human biospecimens and associated information. Because biosamples or data include genetic information, which is sometimes referred to as “the ultimate personal information”, while they are valuable resources for biomedical research, we need to handle them with great care. It is sometimes difficult to distinguish between ethical and non-ethical in this diverse society since people think or become interested in things in a different way. I hope my research would make a contribution to the betterment of society.

Biography

2002　BL, Faculty of Letters, Doshisha University
2013　MPH, Graduate School of Medicine, The University of Tokyo
2015　Project Researcher, Department of Biomedical Ethics,
          Graduate School of Medicine, The University of Tokyo
2016　Senior Researcher, Keio Research Institute of SFC
2020　Completed Ph.D program without a Ph.D. degree,
          Graduate School of Medicine, The University of Tokyo
2020　Research Fellow, Uehiro Research Division for iPS Cell Ethics,
          Center for iPS Cell Research and Application
2022　Research Fellow, Kyoto University Institute for
　　　 the Advanced Study of Human Biology
          Visiting Researcher, Uehiro Research Division for iPS Cell Ethics,
          Center for iPS Cell Research and Application

Research activities

Selected publications

  1. Oikawa M, Nakazawa E, Takimoto Y, Akabayashi A. Biobanks and public involvement activities: a literature review on the concept of “involvement” in the area of biomedical research. 2018; 28(2):137-151. (in Japanese)

  2. Maeda S, Kobayashi R, Kamishiraki E, Oikawa M, Ishikawa E. Handling complications caused by phlebotomy for blood sampling: results of a nationwide survey in Japan. Journal of Patient Safety & Conflict Management. 2018; 11:14-28.

  3. Oikawa M, Ishikawa E, Maeda S. Clinical ethics consultation: efforts to the initiation of CEC certified program in ASBH. Journal of Patient Safety & Conflict Management. 2018; 11:29-36. (in Japanese)

  4. Oikawa M, Nakazawa E, Takimoto Y, Akabayashi A. Ethical and social issues concerning dynamic consent. Journal of Patient Safety & Conflict Management 2016; 10:55-70. (in Japanese)

  5. Oikawa M, Fujita M, Akabayashi A. Requirements for general consent and their ethical underpinnings: considering the ideal form of general consent. Journal of the Japan Association for Bioethics 2014; 24(1):235-243. (in Japanese)

  6. Oikawa M, Fujita M, Takimoto Y, Akabayashi A. Issues of general consent for biobanks: from current situations in Japan and overseas. Current Movement of Neuroethics 2014; 43-65. (in Japanese)